QSV Biologics, Ltd. and Critical Biologics Corp. Sign 2nd Contract for cGMP Manufacture of Plasma Gelsolin
18-Aug-2008 -
QSV Biologics, Ltd (QSV) and Critical Biologics Corp. (CBC) announced the signing of a second, repeat business, contract for the cGMP manufacturing of recombinant human plasma gelsolin (Solinex(TM)) being targeted for various critical care applications and end-stage renal disease patients on ...
clinical trials
dialysis
diseases
+4